Avenue Therapeutics Inc
0.00 (0.0%)
Volume 0
Bid Price 1.28
Ask Price 1.34
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Avenue Therapeutics Inc ATXI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.29 04:01:23
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 1.06 - 18.75
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 1.29 USD


Draw Mode:

Avenue Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.13M 5.53M 5.49M $ - $ - -3.34 -0.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 322.23k 30.50%

more financials information »

Avenue Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ATXI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.351.4351.281.34173,367-0.06-4.44%
1 Month1.192.351.151.772,071,6770.108.4%
3 Months1.662.351.061.69870,125-0.37-22.29%
6 Months4.11916.651.065.393,530,254-2.83-68.68%
1 Year11.2518.751.066.933,101,211-9.96-88.53%
3 Years166.50188.401.0614.671,186,933-165.21-99.23%
5 Years55.80188.401.0616.21732,432-54.51-97.69%

Avenue Therapeutics Description

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.